Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Spruce Biosciences (SPRB) Non Operating Income (2022 - 2024)

Spruce Biosciences (SPRB) has disclosed Non Operating Income for 3 consecutive years, with $808000.0 as the latest value for Q3 2024.

  • Quarterly Non Operating Income fell 43.22% to $808000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Sep 2024, up 27.93% year-over-year, with the annual reading at $119000.0 for FY2021, 40.5% down from the prior year.
  • Non Operating Income for Q3 2024 was $808000.0 at Spruce Biosciences, down from $938000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $1.4 million in Q3 2023, with the low at $58000.0 in Q1 2022.
  • Average Non Operating Income over 3 years is $781250.0, with a median of $873000.0 recorded in 2024.
  • The sharpest move saw Non Operating Income skyrocketed 1125.96% in 2023, then crashed 43.22% in 2024.
  • Over 3 years, Non Operating Income stood at $104000.0 in 2022, then surged by 1268.27% to $1.4 million in 2023, then plummeted by 43.22% to $808000.0 in 2024.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $808000.0, $938000.0, and $1.1 million for Q3 2024, Q2 2024, and Q1 2024 respectively.